Shengtai Pharmaceutical, Inc. has been awarded the China Good Manufacturing Practice (GMP) certificate for its new glucose manufacturing facility. The new facility has an annual production capacity of 120,000 tons, which, when combined with existing capacity, now gives Shengtai the ability to produce 180,000 tons of glucose per year. The company’s major revenue driver is pharmaceutical grade glucose, and the lack of production capacity has constrained earnings. More details...

Stock Symbol: (OTCBB: SGTI)